New Delhi: An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal...
Sequoia Capital-backed Indigo Paints on Tuesday said it has mopped up Rs 348 crore from anchor investors ahead of its initial share-sale, which will...